Introduction
============

The marine environment, covering 70% of the earth\'s surface and 95% of its tropical biosphere represents 34 of the 36 phyla of life and provides a fascinating variety of biodiversity exceeding that of the terrestrial environment. Not surprising is that marine organisms produce an unprecedented molecular diversity by the incorporation of elements like bromine that are not readily available to terrestrial species. Partially responsible for the unique secondary metabolism of marine life are the ecological pressures in the marine ecosystem including significant competition for space, deterrence of predation and a high level of symbiosis between different species ([@bib30]). Due to the biogenetic origin, marine organism secondary metabolites possess a number of structural differences as compared to terrestrial natural products. In addition, marine plants, mostly of the algal class (nonvascular), are unrelated to the majority of the terrestrial flora; similarly, the marine invertebrates such as sponges (Porifera), coelenterates (Cnidaria) and mollusks (Mollusca) are also not closely related to their terrestrial counterparts ([@bib42]). Over 12,000 compounds from marine invertebrates (phyla: Annelida, Arthropoda, Brachiopoda, Bryozoa, Chordata, Cnidaria, Echinodermata, Hemichordata, Mollusca, Nematoda, Platyhelminthes, Porifera), algae (phyla: Chlorophycota, Chromophycota, Chromophyta, Cyanophycota, Euglenophycota, Rhodophycota), and microorganisms (bacteria, fungi and protozoa), have been discovered by a relative few marine research groups ([@bib6]). Natural products from the oceans have been reviewed by infectious disease such as for antiparasitic drugs ([@bib24]), antituberculosis agents ([@bib13]), and antiHIV agents ([@bib15]). Furthermore, there are some excellent general and extensive reviews focusing on marine natural products such as "Marine bioprospecting---trawling for treasure and pleasure" ([@bib9]), "The influence of natural products upon drug discovery" ([@bib41]), "Marine natural products" ([@bib14]), and Marine Pharmacology 1999 and 2000 ([@bib36], [@bib35]). The application of synthetic modifications and biocatalysis on the production of marine natural product libraries has been reviewed in: "Enhancing marine natural product structural diversity and bioactivity through semisynthesis and biocatalysis" in Current Pharmaceutical Design ([@bib17]).

In this paper we have focused on the marine indole alkaloids due to the significant activity that they have elicited in cancer or cytotoxicity assays and would also like to draw attention to the tremendous unexplored potential this class of secondary metabolites may have on neurological targets and behavioral diseases.

A variety of marine sources including sponges, tunicates, red alga, acorn worms, and symbiotic bacteria have been shown to generate indole alkaloids, which represent the largest number and most complicated of the marine alkaloids (1 / 4 of total alkaloids) ([@bib27]). The alkaloids obtained from marine organisms frequently possess novel frameworks while in other cases terrestrially related compounds clearly exist. Marine metabolites often possess complexities such as halogen substituents. Their structure elucidation, chemical modification, stereochemistry, synthesis, and pharmacology have received a great deal of interdisciplinary attention from areas of research other than chemistry and include pharmacology, physiology, and medicine.

In this report we have focused on the pharmacologically active indole alkaloid marine natural products that have been shown to have biological activity, including cytotoxic, antiviral, antimicrobial, antiparasitics, anti-inflammatory, antiserotonin, Ca^2+^, calmodulin-antagonistic activity and antitopoisomerase-I activity, along with in vivo activity when available.

Cytotoxic indole alkaloids
==========================

*Dragmacidin* \[*1*\], is a bisindole alkaloid isolated from a deep water marine sponge *Dragmacidin* sp. and showed cytotoxicity with an IC~50~ of 15 μg/mL against P-388 cell lines and 1--10 μg/mL against A-549 (human lung), HCT-8 (human colon), and MDAMB (human mammary) cancer cell lines in vitro ([@bib28]). *Dragmacidin* \[*1*\] and a number of marine natural products including *2* and *3* contain two indole groups joined by a piperazine ring system.

*Staurosporine* \[*4*\], an indolo \[2,3-α\] carbazole alkaloid, possesses cytotoxicity against a number of experimental tumor cell lines ([@bib37]). Staurosporine was first identified from *Streptomyces staurosporeus* Awaya (AM-2282) and other actinomycetes, including *Streptomyces actuosus* and *Streptomyces* strain M-193. The ED~50~ values of staurosporine were shown to be 0.0024 and \< 0.08 μg/mL against KB and P-388, respectively. This study also revealed that staurosporine did not inhibit tubulin polymerization or disrupt micro tubular function at concentrations of 6 and 32 μg/mL, whereas the other antitumor agents, vincristine, vinblastine, and colchicine, exhibit a characteristic inhibition of cell mitosis in metaphase and prevents assembly of microtubules. *Eudistomin K* \[*5*\] isolated from the Caribbean ascidian *Eudistoma olivaceum*, was described as an antitumor lead against L-1210, A-549, HCT-8 and P-388 cell lines, with an in vitro IC~50~ of P-388 reported as 0.01 μg/mL ([@bib31]). *Grossularine 1* and *2* \[*6*, *7*\], isolated from the tunicate *Dendrodoa grossularia*, possess cytotoxic properties, against L-1210 (ID~50~ 6 and 4 μg/mL, respectively), WiDr (colon) and MCF7 (breast) (both are \< 0.01 μg /mL) ([@bib38]), and also appear to act as a monointercalating agent of DNA. *Halocyamine A* and *B* \[*8*, *9*\] are tetrapeptide-like metabolites isolated from the solitary ascidian *Halocynthia roretzi* and exhibited cytotoxic activity against neuronal cells cultured from fetal rat brain, mouse neuroblastoma N-18 cells, and human hepatoma Hep-G2 cells. The distribution of halocyamine A and B was only in the "morula"-like cells, the most plentiful cell type (more than 50%) among the *H. roretzi* hemocytes ([@bib2]). From the Caribbean deep-sea sponge *Spongosorites ruetzleri*, *topsentin* \[*10*\] was shown to possess a bis (indolyl) imidazole structure and exhibits in vitro activity against P-388 (IC~50~ 3.0 μg/mL) and human tumor cells (HCT-8, A-549, T47D, 20 μg/mL) and in vivo activity against P-388 (T/C137%, 150 mg/kg) and B16 melanoma (T/C 144%, 37.5 mg/kg) ([@bib51]). The evaluation of topsentin analogues for biological activity showed that the introduction of a hydroxyl group enhances the cytotoxicity while bromination diminishes activity. *Hyrtiosins A* and *B* \[*11*, *12*\], isolated from the Okinawan sponge *Hyrtios erecta* exhibited cytotoxic activities greater than 5-hydroxyindole-3-aldehyde, which was reported to be active in vitro against human epidermoid carcinoma KB cells (IC~50~ 4.3 μg/mL) ([@bib27]). *Nortopsentins A, B,* and *C* \[*13*, *14*, *15*\], isolated from the Caribbean deep-sea sponge *S. ruetzleri*, possess the unique imidazolediylbis\[indole\] skeleton and inhibits activity against P-388 cells with IC~50~ values of 7.6, 7.8, and 1.7 μg/mL, respectively ([@bib47]). Methylated derivatives of the nortopsentins had improved activity against P-388 cells when compared to that of the parent compound. *Eudistomin E* and *Eudistalbin A* \[*16*, *17*\] were shown to possess cytotoxic activities with ED~50~ \< 0.005 and 3.2 μg/mL, respectively, in vitro against KB cells ([@bib1]) and were extracted from the marine tunicate *Eudistoma album* with EtOH. *Dragmacidin D* \[*2*\], a new bis (indole)-derived sponge metabolite, was isolated from the sponge *Spongosorites* sp. and exhibits anticancer activity in vitro against P-388 and A-549 with IC~50~ values of 1.4 and 4.4 μg/mL, respectively ([@bib52]). *Makaluvamine G* \[*18*\] is structurally related to the discorhabdins and was isolated from the Indonesian sponge *Histodermella* sp. and was shown to be cytotoxic against P-388, A-549, HT-29, MCF-7 (human breast cancer), and KB with IC~50~ values of 0.5, 0.5, 0.5, 0.5, and 0.4 μg/mL, respectively ([@bib10]). Two isomeric cyclo-heptapeptides named *phakellistatin 3* and *isophakellistatin 3* \[*19*, *20*\] were identified from the Western Indian marine sponge *Phakellia carteri* ([@bib43]). A significant difference in the activity was observed with the photo-Trp indole ring juncture, phakellistatin (*trans*-ring juncture) showing inhibition of P-388, while isophakellistatin (*cis*-ring juncture) showed no significant effects. *Isoaplysin A* \[*21*\] is a tryptophan-derived marine natural product, isolated from the Okinawan marine sponge *Aplysina* sp. ([@bib29], [@bib19]) and was shown to be weakly cytotoxic against murine lymphoma L-1210 (IC~50~ 11.5 μg/mL) and KB (31% inhibition at 20 μg/mL) cells. The [d]{.smallcaps}-6-bromopypaphorine exhibited no cytotoxic activity. Aplysinopsin and methylaplysinopsin showed comparative cytotoxicity, with an IC~50~ of 2.3 and 6.4 μg/mL, respectively, against L-1210, and 3.5 μg/mL (aplysinopsin) and 6.7 μg/mL (methylaplysinopsin) against KB. *Gelliusines A* and *B* \[*22*, *23*\] are two diastereometric brominated tris-indole alkaloids occurring as enantiomeric pairs, isolated from a deep water New Caledonian sponge *Gellius* or *Orina* sp. ([@bib4]). The inhibition of KB, P-388, P-388/dox, HT-29 and NSCLCN-6 cell lines for *22* and *23* was evaluated and shown to yield IC~50~ values of between 10 and 20μg/mL. The Okinawan marine sponge *Ircinia* sp. yielded an indole alkaloid named *konbamidin* \[*24*\], which exhibited cytotoxicity against Hela cells in vitro with an IC~50~ value of 5.4 μg/mL ([@bib49]). *Kapakahine B* \[*25*\], a cyclic hexapeptide with an α-carboline ring system, was isolated from the marine sponge *Cribrochalina olemda* ([@bib40]). This peptide showed moderate cytotoxicity against P-388 murine leukemia cells with an IC~50~ value of 5.0 μg/mL. *Styelin D*, a 32-residue peptide isolated from the blood cells (hemocytes) of the solitary ascidian *Styela clava*, contains two novel amino acids, dihydroxy-arginine and dihydroxy-lysine, and two distinctly unusual amino acids including, 6-bromotryptophan and 3,4-dihydroxyphenylalanine ([@bib50]). *Styelin D* exhibited cytotoxicity against HCT-116 cells with an IC~50~ value of 10.1 μg/mL, and human ME-180 cervical epithelial cells with an ED~50~ value of 50 μg/mL. *Topsentin B1* and *B2* \[*26*, *27*\] are bisindole alkaloids, isolated from the Mediterranean marine sponge *Rhaphisia lacazei*, which inhibit human broncopulmonary cancer cells NSCLC-N6 (IC~50~ 12.0 and 6.3 μg/mL, respectively) ([@bib11]). *Pibocin B* \[*28*\], isolated from the ascidian *Eudistoma* sp. obtained in the Sea of Japan, exhibited cytotoxicity against mouse Ehrlich carcinoma cells with an ED~50~ value of 25 μg/mL ([@bib34]). *Convolutamydine A* \[*29*\], extracted from *Amathia convoluta* collected in the Gulf of Mexico near Florida, was shown to have significant activity against HL-60 human plomyelocytic leukemia cells, including a change in culture plate adhesion, growth arrest, and phagocytosis of particles at 0.1--25 μg/mL ([@bib23]). *Manzamine B*, *E*, and *F*, \[*30*, *31*, *32*\] collected from various sponges including an *Amphimedon* sp. throughout the world, have been shown to have IC~50~ values of 6.0, 5.0, and 5.0 μg/mL, respectively, against P-388 murine leukemia cells. These metabolites have recently been discussed in our detailed review included in the series the "Alkaloids" 2003 which discusses their biological activity against cancer, infectious diseases and in particular the highly promising activity against malaria and tuberculosis ([@bib18]).

Antiviral activity
==================

*Eudistomin K* and *L* \[*5, 33*\], contain a novel oxathiazepine ring and were isolated from the Caribbean tunicate *E. olivaceum* ([@bib44]). They inhibit HSV-1 growth at 0.25 and 0.10 μg/disk, respectively. In further investigations, seventeen *eudistomins* (*A--Q*) from *E. olivaceum* were divided into four groups (group 1: simple β-carbolines, including *eudistomins D* \[*34*\], *J* \[*35*\], *N* \[*36*\], and *O* \[*37*\]; group 2: pyrrolyl-β-carbolines, including *eudistomins A \[38\]*, *B \[39\]* ([@bib3]), and *M* \[*40*\]; group 3: pyrrolinyl-β-carbolines, including *eudistomins G* \[*41*\], *H* \[*42*\], *I* \[*43*\], *P* \[*44*\], and *Q* \[*45*\]; and group 4: tetrahydro-β-carbolines with an oxathiazepine ring, including *eudistomins C* \[*46*\], *E* \[*16*\], *F* \[*47*\], *K* \[*5*\], and *L* \[*33*\]) ([@bib45]). The eudistomins containing the oxathiazepine ring (*C*, *E*, *F*, *K*, and *L*) showing the most significant antiviral activity against HSV-1, of which *C* and *E*, with a phenolic group were active down at 0.005--0.01 μg/disk. The trend of antiviral potency of eudistomins was in the order of group 4 (*C*, *E*, *K*, and *L*) ≫ group 3 (*H* and *P*) = group 1 \[*D* and *N* (*O*)\] \> group 2 (*A* and *B*). The substituent (Br and/or OH) on the β-carboline also affects the antiviral activity of eudistomins, which can be expressed as *E* (5-Br, 6-OH) \>  *C* (6-OH) \>  *L*(6-Br) =  *K* (7-Br) and *P* (6-OH, 7-Br) = H (6-Br) \>  *C* (7-Br) ≈  *Q* (6-OH) ≈ I (no substitution). *Eudistomins C* and *E* possess the activities against RNA viruses such as Coxsachie A-21 virus and equine rhinovirus and against DNA viruses such as HSV-1, HSV-2, and Vaccinia virus. The acetylation on the phenol and primary amine functional groups of *eudistomin C* reduces its activity by 100-fold. Eudistomins were also isolated from the New Zealand ascidian *Ritterella sigillinoides* ([@bib31]) and showed antiviral activity in vitro against Herpes simplex Type I and Polio vaccine Type I viruses. The similar activity trend was also reported as *eudistomin C* and *K* (0.04--0.05 μg/disc) \>  *debromoeudistomin K* and *eudistomin K sulfoxide* (0.4 μg/disc) \>  *eudistomin O* (0.5 μg/disc) \> β-carboline (2 μg/disc). *Topsentin* and *bromotopsentin* \[*10*, *48*\] were isolated from the Caribbean deep-sea sponge *S. ruetzleri* collected in the Bahamas and possess Bis (indolyl) imidazole structures ([@bib51]). They exhibited antiviral activities in vitro against HSV-1, Vesivular stomatitis virus (VSV), and the corona virus A-59. *Fascaplysin* and *homofascaplysin A cation* \[*49*, *50*\], isolated from the Benga Lagoon sponge *Fascaplysinopis reticulata*, possess antiviral properties, with the inhibitions against reverse transcriptase (at 1 mg/mL): 81%, 58%, and 94%, respectively ([@bib22]). *Dragmacidin D* (*2*), a bis (indole)-derived sponge metabolite, isolated from sponge *Spongosorites* sp. inhibited in vitro replication of feline leukemia virus (FeLV) with an IC~50~ of 6.25 μg/mL ([@bib52]). *Coscinamide A*, *B*, and *C* \[*51*, *52*, *53*\], isolated from the organic extract of *Coscinoderma* sp. collected in Papua, New Guinea, showed activity in the NCI\'s XTT-based anti-HIV assay ([@bib8]). Extractions that were isolated from *Flustra foliacea* using crude petroleum ether were shown to strongly inhibit influenza virus plaque growth ([@bib39]).

Antimicrobial/antiparasitic activity
====================================

*Dihydroflustramine C* and *Flustramine D* \[*54*, *55*\], are interesting in regard to the marine origin and belonging to the physostigmine structural class of alkaloids, reported from the marine bryozoan *F. foliacea* ([@bib32]). The alkaloid fraction mainly containing these two compounds exhibited a wide antibacterial spectrum including activity against *Enterobacter cloacae, Escherichia coli, Klebsiella pneumoniae, Proteus vulgaris, Pseudomonas aeruginosa, Salmonella typhimurium, Serratia marcescens, Staphylococcus aureus* and *Staphylococcus epidermidis* in disc diffusion assays (0.5 mg/disc). *Eudistomins A-Q*, isolated from the Caribbean tunicate *E. olivaceum*, displayed a widely differing degree of antimicrobial activities ([@bib45]). The eudistomins containing the oxathiazepine rings are generally most active. Some eudistomins are active against *Bacillus subtilis* (*D*, *I*, and *Q*) or *Saccharomyces cerevisiae* (*H*) or both (*P*), while others are active against *E. coli* and *Penicillium atrovenetum* \[*C*, *K*, *L*, and *N*(*O*)\]. *Fascaplysin* \[*49*\], biogenetically derivable from tryptamine and structurally belonging to the pentacyclic quaternary salt, was isolated from the Fijian sponge *Fascaplysinopsis* sp. ([@bib46]). Fascaplysin showed activities against the growth of several microbes, with a 15-mm zone at 0.1 μg/disk against *S. aureus*, 8-mm zone at 5 μg/disk against *E. coli*, 11-mm zone at 1 μg/disk against *Candida albicans*, and 20-mm zone at 0.1 μg/disk against *S. cerevisiae*. *Halocyamine A* and *B* \[*8*--*9*\], modified tetrapeptides, were isolated from the solitary ascidian *H. roretzi* from Japan ([@bib2]). *Halocyamine A* inhibited the growth of several microbes, including the Gram-positive bacteria *B. subtilis* (MIC 150 μg/mL), *Bacillus megaterium* (MIC 50 μg/mL), *Bacillus cereus* (MIC 100 μg/mL), and the yeast *Candida neoformans* (MIC 100 μg/mL). *Halocyamine B* displayed the comparative antimicrobial activities as *A*. *Chelonin A*, *B* and *bromochelonin B* \[*56*, *57*, *58*\], isolated from the marine sponge *Chelonaplysilla* sp., are another example of antimicrobial tryptophan derivatives ([@bib7]). They exhibited activity against *B. subtilis* at a concentration of 100 μg/disk. *Dragmacidin D* \[*2*\], a new bis (indole)-derived sponge metabolite, isolated from the sponge *Spongosorites* sp. ([@bib52]) inhibited the growth of several microbes, including *E. coli* (MIC 15.6 μg/mL), *B. subtilis* (MIC 3.1 μg/mL), *Candida aeruginosa* (MIC 62.5 μg/mL), *C. albicans* (MIC 15.6 μg/mL), and *C. neoformans* (3.9 μg/mL). *Styelin D*, a peptide isolated from the blood cells (hemocytes) of the solitary ascidian *S. clava*, displayed antimicrobial activity against methicillin-resistant and susceptible strain of *S. aureus* ([@bib50]). *Styelin D* has an effect on the outer and inner membranes on *E. coli*, making the outer membranes permeable to nitrocefin (a β-lactamase substrate) and the inner membranes permeable to *o*-nitrophenyl β-[d]{.smallcaps}-galactopyranoside (a β-galactosidase substrate). *Nortopsentins A*, *B* and *C* \[*13*--*15*\], isolated from the Caribbean deep-sea sponge *S. ruetzleri*, exhibited antifungal activity against *C. albicans* ([@bib47]). From the Bahamian deep water marine sponge *Discodermia* sp., antifungal alkaloids *discobahamin A* and *B* \[*59*, *60*\] were isolated ([@bib16]). They showed weak activity against the yeast *C. albicans*. *Pibocin B* \[*28*\], isolated from the ascidian *Eudistoma* sp. obtained from the Sea of Japan, was shown to have antimicrobial activity against *B. subtilis, C. albicans*, and *S. aureus* ([@bib34]). *Hamacanthin B* \[*61*\] was obtained from *Hamacantha* sp, a deep-water marine sponge, and was shown to inhibit activity of *C. albicans* and *C. neoformans* ([@bib21]). Dichloromethane extractions from the cheilostome bryozoan *F. foliacea* exhibited antimicrobial activity against *B. subtilis* ([@bib39]). *Rhopaladin C* \[*62*\], isolated from the Okinawan tunicate *Rhopalaea sp.,* was shown to have antimicrobial activity against *Corynebacterium xerosis* and *Sarcina lutea* (MIC, 16 μg/mL each) ([@bib48]). The manzamine alkaloids are now represented by approximately 40 different reported structures which can be divided into those which contain an indole moiety (as part of a beta-carboline system and represented by *30*--*32*) and those without a beta-carboline system. The β-carboline system has been shown to play a prominent role in the very promising antimalarial activity for this class of alkaloids (reviewed in [@bib18]). *Jasplakinolide* \[*63*\], obtained from a sponge collected in Fiji, was shown to have an MIC of 25 μg/mL against *C. albicans.* For a review of marine natural products with significant activity against infectious diseases please see our review "Marine natural products and their potential applications as anti-infective agents" in Lancet Infectious Diseases 2003 by [@bib12].

Anti-inflammatory indole alkaloids
==================================

*Chelonin A* \[*56*\], isolated from the sponge *Chelonaplysilla* sp. found in a marine lake in Palau exhibited antiinflammatory activity in addition to the antimicrobial activity discussed earlier ([@bib7]). *Chelonin A* showed a 60% inhibition against PMA-induced inflammation in a mouse ear model (50 μg/ear), but shows no in vitro inhibition against bee venom phosopholipase A~2~. *Dragmacidin* \[*1*\], isolated from the sponges *Dragmacidin* sp. and *Hexadella* sp. has been shown to have anti-inflammatory activity against bee venom PLA~2~ and mouse ear edema in vitro and in vivo assays, respectively ([@bib20]).

Activity of indole alkaloids on serotonin receptors
===================================================

*Gelliusine A* \[*22*\], is a brominated tris-indole alkaloid occurring as enantiomeric pairs, isolated from a deep water New Caledonian sponge *Gellius* or *Orina* sp. ([@bib4]). At higher concentrations (5--70 μg/mL), *gelliusine A* causes a serotonin-like and methysergide-sensitive contraction; while at low concentration, it is able to antagonize serotonin-induced contraction, indicating the ability to block the serotoninergic receptor. In a later investigation, *gelliusines A*, *B*, *E* and *F* \[*22*--*23*, *64*--*65*\] were submitted to a series of receptor binding assays at a concentration of 5 μg/mL ([@bib5]), including the somatostatin receptor site (the inhibition of specific ligand binding were 100%, 100%, 87% and 91%, respectively), the neuropeptide Y receptor (90%, 62%, 63% and 67%, respectively), and the human B2 bradykinin receptor site (100%, 93%, 63% and 89%, respectively) ([@bib5]). A number of halogenated indoles related to *isoaplysin A* \[*21*\] have shown interesting selectivity for serotonin receptors when evaluated for affinity toward the 5-HT~2A~ and 5-HT~2C~ receptors. Clearly one of the more interesting and unexplored application for marine natural products is their potential selective affinity for various neurological targets like the 5-HT subtypes and the resulting impact on behavior in whole animal studies (see our discussion in [@bib19]).

Ca-releasing activity
=====================

*9-Methyl-7-bromoeudistomin D* \[*66*\], isolated from the Caribbean tunicate *E. olivaceum*, was found to induce Ca^2+^ release from the sarcoplasmic reticulum ([@bib26]). The comparison of several eudistomin analogues suggested that the 9-methyl group is quite important to the activity, and the bromine substituent in the β-carboline is better than chlorine or iodine. The SAR also indicated that the alkyl substitution to N-2 in the β-carboline lead to decrease the activity. Compared to caffeine, 9-methyl-7-bromoeudistomin was approximately 1000 time more potent in causing Ca^2+^ release from the sarcoplasmic reticulum of skeletal muscle. *7-Bromoeudistomin D* \[*67*\], obtained by demethylation of *7-bromo-O*-*methyleudistomin D*, was found to be 400 times more potent than caffeine in Ca^2+^ releasing action ([@bib45]). Isolated from *F. foliacea*, *flustramines A* and *B* \[*68*--*69*\], were found to cause relaxation of both skeletal and smooth muscle ([@bib39]). *Barretin* \[*70*\], isolated from the Swedish cold-water sponge *Geodia baretti,* was shown to inhibit contractions of a Guinea-pig ileum ([@bib33]).

Calmodulin-antagonistic activity
================================

The Okinawan tunicate *Eudistoma glaucus* afforded *eudistomidin A* \[*71*\] and was shown to be the first calmodulin antagonist from marine origin ([@bib25]). IC~50~ (2 × 10^− 5^M) against calmodulin-activated brain phosphodiesterase was 15 times more potent than W-7 (3 × 10^− 4^M), a well-known calmodulin antagonist.

Enzyme inhibitors
=================

Isolated from the Okinawan tunicate *Rhopalaea* sp., *Rhopaladin B* \[*72*\], was the only compound from the series *Rhopaladin A*--*D* that was shown to inhibit cyclin dependent kinase 4 and c-erbB-2 kinase with an IC~50~ of 12.5 and 7.4, respectively ([@bib48]). *Dragmacidin D* and *E* \[*2*, *3*\], isolated from *Dragmacidin* sp., were shown to inhibit serine-threonine protein phosphatases. *Dragmacidin D* (*2*) was also shown to inhibit neural nitric oxide synthase (βNOS), which may prove to help in the treatment of Huntington\'s, Parkinson\'s, and Alzheimer\'s diseases ([@bib53]).

Anti-topoisomerase-I activity
=============================

The evaluation of an Indonesian sponge *Histodermella* sp., collected from Manado Bay, afforded *makaluvamine G* \[*18*\], a structural analog to the discorhabdin compounds, and exhibited moderate inhibition of topoisomerase-I (IC~50~ 3.0 μM) ([@bib10]). The activity of inhibition of RNA (IC~50~ 15 μM), DNA (IC~50~ 15 μM), and protein (IC~50~ 21 μM) synthesis was also reported.

Discussion
==========

A wide diversity of biologically active indole alkaloids have been reported from marine sources. Indole alkaloids derived from *Dragmacidin* sp. have been shown to exhibit cytotoxic activity, anti-inflammatory activity, and to inhibit enzyme activity. The Fijian sponge *Fascaplysinopsis* sp. produced cytotoxic and antiviral compounds. *S. staurosporeus* and *D. grossularia*, which yielded *staurosporine* and *grossularine 1* and *2*, respectively, both were shown to possess cytotoxic properties. *Eudistomins A-Q* were obtained from the ascidian *E. olivaceum.* Cytotoxic activity was characteristic of these alkaloids, as well as antiviral, Ca^2+^, and antimicrobial. Indole alkaloids isolated from *H. roretzi* were shown to exhibit cytotoxicity and antimicrobial activity. *S. ruetzleri* afforded compounds that possessed cytotoxic, antiviral, and antimicrobial activity. The Okinawan sponges *H. erecta* and *Aplysina* sp. gave compounds that exhibited cytotoxic activity. The Indonesian sponge *Histodermella* sp. yielded *makaluvamine G*, which was shown to have cytotoxic and anti-topoisomerase-1 activity. Several indole alkaloids were isolated from *Eudistoma* sp. and were shown to exhibit cytotoxic, antimicrobial, and calmodulin-antagonistic activities. *P. carteri, Ircinia* sp., and *Cribochalina olemda* all possessed indole alkaloids that had cytotoxic activity. Indole alkaloids isolated from the New Caledonian sponge *Gellius* or *Orina* sp. was shown to have cytotoxic activity, as well as activity against serotonin receptors.

Conclusion
==========

The biological activity of marine indole alkaloids is clearly a product of the unique functionality and elements involved in the biosynthesis of marine natural products. For instance, the bromination of many of the mentioned natural products has the potential to increase the biological activity significantly. The cytotoxic activity of *grossularine 1* is increased as compared to *grossularine 2* due to the extra indole group in place of the benzene ring. As seen with the nortopsentin compounds, bromination does not always result in better activity. *Nortopsentin B* with only one R group brominated is cytotoxic at 0.2 μg/mL and more active than *nortopsentin A* with two brominated R groups and *nortopsentin C* which also has one bromine opposite that of *nortopsentin B* and this change decreases its activity to 1.7 μg/mL (against P-388 cells.) The decrease in cytotoxic activity can also be observed with *topsentin B1* and *B2* where the addition of bromine reduces the activity by half. In antiviral activity, the specific placement of substituents is vital as can be seen with *eudistomin K* and *L*. In *eudistomin K*, with the bromine placed in the R3 position, as opposed to the R2 position as in *L*, the growth inhibition was shown to be 0.25 μg/mL, 0.15μg/mL more active than *L*. *Eudistomin K* was also shown to be active against Herpes simplex Type I and Polio vaccine Type I viruses, while *L* was not. Concerning the activity of indole alkaloids on serotonin receptors, the addition of an indole group, as seen in *gelliusine A* and *B*, to the main Gelliusine structure causes a significant increase in the inhibition of ligand binding, the neuropeptide Y receptor, and the human B2 bradykinin receptor site. *Gelliusine E* shows the poorest activity, which may be due to the lack of the extra indole group of *gelliusine A* and *B* and the extra bromine carried by *gelliusine F*. In the case of the *isoaplysin* related alkaloids the addition of bromine to the indole system elicited very significant improvements in binding selectivity to the various 5-HT subtypes. This clearly indicates that these halogenated marine indole alkaloids are certain to help define the function of the various 5-HT subtypes in addition to the identification of drug leads with potential clinical applications.
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